Skip to main content
Clinical Trials/NCT07725107
NCT07725107Active, not recruitingNot Applicable

Efficacy of Topically Applied Oxygen-Based Therapy Versus Platelet-Rich Fibrin for Medication-Related Osteonecrosis of the Jaws: A Randomized Controlled Trial

Mansoura University1 site in 1 country36 target enrollmentStarted: April 1, 2026Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
36
Locations
1
Primary Endpoint
Complete mucosal healing (bone coverage)

Study Overview

Brief Summary

A randomized clinical trial comparing Blue®m oral gel and autologous PRF membrane as adjuncts to surgical debridement in BRONJ/MRONJ patients.

Detailed Description

Thirty-six BRONJ/MRONJ patients will be randomly allocated to receive either Blue®m oral gel or PRF membrane following surgical debridement, and healing outcomes will be evaluated clinically.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient Age: ≥18 years.
  • Patients diagnosed with BRONJ/MRONJ Stage 1-3 (AAOMS criteria).(25)
  • History of antiresorptive or antiangiogenic drug use.
  • Patients willing to participate in the study's follow-up intervals and to provide informed consent.

Exclusion Criteria

  • Previous radiotherapy to head and neck
  • Uncontrolled systemic disease (e.g., uncontrolled diabetes)
  • Pregnancy or lactation
  • Known allergy to Blue®m components
  • Uncooperative patients.

Outcomes

Primary Outcomes

Complete mucosal healing (bone coverage)

Time Frame: 12 weeks post-intervention

Mucosal healing will be evaluated clinically by direct inspection of the surgical site.

Secondary Outcomes

  • Soft-Tissue Healing(- One week after intervention - 2 weeks after intervention - 4 weeks after intervention - 12 weeks after intervention)
  • Postoperative pain(- 1 week postoperatively - 4 weeks postoperatively)
  • Hard Tissue(- Preoperatively - 12 weeks postoperative)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Topical Oxygen Therapy for BRONJ | Clinical Trial